BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19549104)

  • 1. Nucleolar size in choroidal and ciliary body melanomas and corresponding hepatic metastases.
    Al-Jamal RT; Toivonen P; Kivelä T
    Acta Ophthalmol; 2010 Jun; 88(4):458-62. PubMed ID: 19549104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
    Al-Jamal RT; Kivelä T
    Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body.
    Al-Jamal RT; Mäkitie T; Kivelä T
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2381-9. PubMed ID: 12766034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases.
    Toivonen P; Mäkitie T; Kujala E; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):1-6. PubMed ID: 14691146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
    Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections.
    Moshari A; McLean IW
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1160-3. PubMed ID: 11328722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma.
    Mäkitie T; Carpén O; Vaheri A; Kivelä T
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2442-9. PubMed ID: 11581181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of prognostic covariates for uveal melanoma.
    Gamel JW; McCurdy JB; McLean IW
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective study of uveal melanoma].
    Tóth J
    Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
    Kujala E; Kivelä T
    Ophthalmology; 2005 Jun; 112(6):1135-44. PubMed ID: 15885792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microcirculation of choroidal and ciliary body melanomas.
    Folberg R; Mehaffey M; Gardner LM; Meyer M; Rummelt V; Pe'er J
    Eye (Lond); 1997; 11 ( Pt 2)():227-38. PubMed ID: 9349418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages and microcirculation in regressed and partially regressed irradiated choroidal and ciliary body melanomas.
    Toivonen P; Mäkitie T; Kujala E; Kivelä T
    Curr Eye Res; 2003 Oct; 27(4):237-45. PubMed ID: 14562175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
    Seregard S; Spångberg B; Juul C; Oskarsson M
    Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye-wall resection.
    Char DH; Miller T; Crawford JB
    Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods].
    Libman ES; Brovkina AF; Bezrukov AV
    Oftalmol Zh; 1989; (6):336-8. PubMed ID: 2622596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.
    Ly LV; Odish OF; Wolff-Rouendaal Dd; Missotten GS; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):658-65. PubMed ID: 19797220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.